---
title: "Sample size calculation"
subtitle: "A High-level Overview"
date: "`r Sys.Date()`"
author: "Márton Kiss MD"
format: 
  beamer:
    theme: "Madrid"
    colortheme: "rose"
    fonttheme: "structurebold"
    fontsize: 8pt
    colorlinks: true
editor: visual
header-includes: |
  \definecolor{myblue}{RGB}{45, 100, 200}
  \setbeamercolor{frametitle}{fg=myblue,bg=white}
---



# Introduction

This presentation provides a high-level overview of sample size calculation in clinical trials. 

We will discuss the key concepts and considerations for estimating the sample size for clinical trials. 

The goal of this presentation however is not to provide a comprehensive guide to sample size calculation, but rather to introduce the main concepts and considerations involved in this critical aspect of clinical trial design.



# Defining the Primary Endpoint

## What is a Primary Endpoint?

- The most crucial outcome measure in a clinical trial, serving as the basis for evaluating the effectiveness of an intervention.
- Predefined before the study begins and reflects the primary objective of the trial.
- Determines when and if the trial can be considered a success.



## Flexibility in Endpoint Selection

- **Exploratory vs. Confirmatory Trials**: Trials exist on a spectrum from exploratory to confirmatory.
  - **Exploratory Trials**: Aim to generate hypotheses or gather preliminary data.
  - **Confirmatory Trials**: Designed to provide robust evidence supporting the efficacy and safety of an intervention.
- The distinction is not always clear-cut; many studies have elements of both.



# Exploratory-Confirmatory Spectrum

<!-- ![Exploratory-Confirmatory Spectrum](images/exploratory_confirmatory_spectrum.png) -->

- **Exploratory Studies**:
  - Hypothesis-generating
  - Flexible design and endpoints
  - Smaller sample sizes
- **Confirmatory Studies**:
  - Hypothesis-testing
  - Rigid design with predefined endpoints
  - Larger sample sizes
- **Spectrum**: Trials can have varying degrees of exploratory and confirmatory characteristics.



# Study Design Overview

## Parallel Design

- Participants are randomly assigned to one of two or more groups (arms).
- Each group receives a different intervention (e.g., new treatment vs. placebo or standard care).
- Outcomes are compared between groups at specified time points.



## Patient Journey in a Parallel Design Trial

- **Enrollment**: Informed consent and eligibility screening.
- **Randomization**: Assignment to treatment or control group.
- **Intervention Period**: Administration of assigned intervention.
- **Follow-Up Assessments**: Scheduled evaluations for efficacy and safety.
- **Completion or Withdrawal**: End of participation or early exit from the study.



# Regulatory Guidance - ICH E9

## International Council for Harmonisation (ICH) E9

- **Title**: *Statistical Principles for Clinical Trials*
- Provides comprehensive guidelines on the statistical considerations in clinical trial design and analysis.
- Emphasizes the importance of:
  - Clear objectives and hypotheses.
  - Appropriate statistical methodologies.
  - Rigorous data analysis and interpretation.



## Key Aspects of ICH E9

- **Design Considerations**:
  - Importance of randomization and blinding.
  - Selection of appropriate endpoints and estimands.
- **Statistical Analysis**:
  - Pre-specification of analysis plans.
  - Handling of missing data.
- **Interpretation of Results**:
  - Distinguishing statistical significance from clinical relevance.
  - Reporting and transparency.



<!-- # # Statistical Power and Significance -->
<!-- #  -->
<!-- # ## Understanding Statistical Power -->
<!-- #  -->
<!-- # - **Definition**: The probability that a study will detect a true effect if it exists (1 - β). -->
<!-- # - **Desired Levels**: Commonly set at 80% or 90%. -->
<!-- # - **Type II Error (β)**: Risk of a false negative, failing to detect a true effect. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Significance Level (α) -->
<!-- #  -->
<!-- # - **Definition**: The probability of rejecting the null hypothesis when it is true (Type I error). -->
<!-- # - **Common Threshold**: Typically set at 0.05. -->
<!-- # - **Type I Error**: Risk of a false positive. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Balancing α and β -->
<!-- #  -->
<!-- # - **Trade-Offs**: -->
<!-- #   - Lowering α reduces the chance of a Type I error but may increase the required sample size. -->
<!-- #   - Increasing power (reducing β) increases the likelihood of detecting true effects but may require more participants. -->
<!-- # - **Optimal Balance**: Depends on the study context and the consequences of errors. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Key Parameters Influencing Sample Size -->
<!-- #  -->
<!-- # - **Effect Size (δ)**: The expected difference between intervention and control groups. -->
<!-- # - **Variability (σ)**: The standard deviation of the outcome measure. -->
<!-- # - **Significance Level (α)**: The threshold for statistical significance. -->
<!-- # - **Power (1 - β)**: The desired probability of detecting an effect. -->
<!-- # - **Dropout Rates**: The anticipated proportion of participants who will not complete the study. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Estimating Effect Size and Variability -->
<!-- #  -->
<!-- # ## Sources of Estimates -->
<!-- #  -->
<!-- # - **Previous Studies**: Published research and meta-analyses. -->
<!-- # - **Pilot Studies**: Preliminary data collection to inform estimates. -->
<!-- # - **Expert Opinion**: Insights from clinicians and researchers. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Challenges and Strategies -->
<!-- #  -->
<!-- # - **Uncertainty in Estimates**: -->
<!-- #   - Effect sizes and variability are often based on limited data. -->
<!-- # - **Conservative Approaches**: -->
<!-- #   - Using smaller expected effect sizes or larger variability to ensure adequate power. -->
<!-- # - **Sensitivity Analyses**: -->
<!-- #   - Assessing how changes in assumptions affect sample size requirements. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Mathematical Foundations - Z-Score Approach -->
<!-- #  -->
<!-- # ## Understanding Z-Scores -->
<!-- #  -->
<!-- # - **Definition**: A Z-score indicates how many standard deviations an element is from the mean. -->
<!-- # - **Application**: Used in hypothesis testing to determine probabilities under the normal distribution. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Sample Size Formula for Comparing Two Means -->
<!-- #  -->
<!-- # \[ -->
<!-- # n = \left( \frac{Z_{1-\alpha/2} + Z_{1-\beta}}{\delta / \sigma} \right)^2 -->
<!-- # \] -->
<!-- #  -->
<!-- # Where: -->
<!-- #  -->
<!-- # - \( n \): Sample size per group -->
<!-- # - \( Z_{1-\alpha/2} \): Z-score for the desired significance level (e.g., 1.96 for α = 0.05) -->
<!-- # - \( Z_{1-\beta} \): Z-score for the desired power (e.g., 0.84 for 80% power) -->
<!-- # - \( \delta \): Expected effect size (mean difference) -->
<!-- # - \( \sigma \): Standard deviation -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Noncentral t-Distribution -->
<!-- #  -->
<!-- # ## When to Use -->
<!-- #  -->
<!-- # - Appropriate for small sample sizes when the population variance is unknown. -->
<!-- # - Adjusts for the additional uncertainty compared to the normal distribution. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Impact on Sample Size -->
<!-- #  -->
<!-- # - **Effect on Calculations**: -->
<!-- #   - Results in a slightly larger sample size compared to using the normal distribution. -->
<!-- # - **Practical Implications**: -->
<!-- #   - Difference is often minimal (±2 participants per group). -->
<!-- #   - Becomes negligible with larger sample sizes. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Accounting for Dropouts -->
<!-- #  -->
<!-- # ## Importance -->
<!-- #  -->
<!-- # - Ensuring sufficient power despite participant attrition. -->
<!-- # - Failure to account for dropouts can lead to underpowered studies. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Adjusting Sample Size -->
<!-- #  -->
<!-- # \[ -->
<!-- # n_{\text{adjusted}} = \frac{n}{1 - \text{Dropout Rate}} -->
<!-- # \] -->
<!-- #  -->
<!-- # - **Example**: -->
<!-- #   - Calculated \( n = 100 \) per group. -->
<!-- #   - Expected dropout rate = 10%. -->
<!-- #   - Adjusted sample size: \( n_{\text{adjusted}} = \frac{100}{0.9} \approx 112 \) per group. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Sample Size as an Estimate -->
<!-- #  -->
<!-- # - **Uncertainty in Parameters**: -->
<!-- #   - Estimates are based on assumptions and available data. -->
<!-- # - **Flexibility**: -->
<!-- #   - Be prepared to adjust the sample size as new information becomes available. -->
<!-- # - **Conclusion**: -->
<!-- #   - The calculated sample size is a guideline, not an exact requirement. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Inverse Approach to Sample Size Estimation -->
<!-- #  -->
<!-- # ## Concept -->
<!-- #  -->
<!-- # - Determine the detectable effect size given a fixed sample size. -->
<!-- # - Useful when resources or feasible participant numbers are limited. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Application -->
<!-- #  -->
<!-- # - **Resource Constraints**: -->
<!-- #   - Budget, time, or population limitations. -->
<!-- # - **Strategic Planning**: -->
<!-- #   - Helps in setting realistic objectives. -->
<!-- #   - Aligns expectations with what is achievable. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Trade-Offs Between Sample Size and Effect Size -->
<!-- #  -->
<!-- # - **Larger Sample Sizes**: -->
<!-- #   - Detect smaller effect sizes. -->
<!-- #   - Require more resources. -->
<!-- # - **Smaller Sample Sizes**: -->
<!-- #   - Detect only larger effect sizes. -->
<!-- #   - May miss clinically meaningful differences. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Decision-Making -->
<!-- #  -->
<!-- # - **Clinical Significance**: -->
<!-- #   - Is the detectable effect size meaningful in practice? -->
<!-- # - **Feasibility**: -->
<!-- #   - Are the required resources available? -->
<!-- # - **Balancing Act**: -->
<!-- #   - Optimize the study design within practical constraints. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Special Considerations for Binary Outcomes -->
<!-- #  -->
<!-- # ## Normal Approximation of the Binomial Distribution -->
<!-- #  -->
<!-- # - **Applicability**: -->
<!-- #   - Valid when sample sizes are large, and probabilities are not near 0 or 1. -->
<!-- # - **Benefit**: -->
<!-- #   - Simplifies calculations using Z-scores. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Sample Size Formula for Proportions -->
<!-- #  -->
<!-- # \[ -->
<!-- # n = \frac{ \left[ Z_{1-\alpha/2} \sqrt{2p(1 - p)} + Z_{1-\beta} \sqrt{p_1(1 - p_1) + p_2(1 - p_2)} \right]^2 }{ (p_1 - p_2)^2 } -->
<!-- # \] -->
<!-- #  -->
<!-- # Where: -->
<!-- #  -->
<!-- # - \( p = \frac{p_1 + p_2}{2} \) -->
<!-- # - \( p_1, p_2 \): Proportions in control and treatment groups -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Introduction to Crossover Trials -->
<!-- #  -->
<!-- # ## Definition -->
<!-- #  -->
<!-- # - Participants receive multiple interventions sequentially. -->
<!-- # - Each participant acts as their own control. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Advantages and Challenges -->
<!-- #  -->
<!-- # - **Advantages**: -->
<!-- #   - Increased statistical efficiency. -->
<!-- #   - Reduced sample size requirements. -->
<!-- # - **Challenges**: -->
<!-- #   - Potential for carryover effects. -->
<!-- #   - Requires careful planning of washout periods. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Adaptive Trial Designs -->
<!-- #  -->
<!-- # ## Overview -->
<!-- #  -->
<!-- # - **Definition**: Trials that allow for modifications based on interim data. -->
<!-- # - **Types of Adaptations**: -->
<!-- #   - Sample size re-estimation. -->
<!-- #   - Dropping or adding treatment arms. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Benefits and Considerations -->
<!-- #  -->
<!-- # - **Benefits**: -->
<!-- #   - Flexibility to respond to data. -->
<!-- #   - Potential for increased efficiency. -->
<!-- # - **Considerations**: -->
<!-- #   - Must maintain trial integrity. -->
<!-- #   - Requires pre-specification and appropriate statistical methods. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Practical Considerations in Sample Size Estimation -->
<!-- #  -->
<!-- # - **Collaboration**: -->
<!-- #   - Involve statisticians early. -->
<!-- # - **Software Tools**: -->
<!-- #   - Use R packages like `pwr` for calculations. -->
<!-- # - **Continuous Evaluation**: -->
<!-- #   - Reassess assumptions as new data emerge. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Examples of Sample Size Calculations -->
<!-- #  -->
<!-- # ## Example 1: Comparing Two Means -->
<!-- #  -->
<!-- # - **Objective**: Detect a mean difference of 5 units. -->
<!-- # - **Parameters**: -->
<!-- #   - \( \sigma = 15 \) units -->
<!-- #   - \( \alpha = 0.05 \) -->
<!-- #   - Power = 80% -->
<!-- # - **Calculation**: -->
<!-- #  -->
<!-- # \[ -->
<!-- # n = \left( \frac{1.96 + 0.84}{5 / 15} \right)^2 = \left( \frac{2.80}{0.333} \right)^2 \approx 70.56 -->
<!-- # \] -->
<!-- #  -->
<!-- # - **Result**: Approximately 71 participants per group. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # ## Example 2: Comparing Two Proportions -->
<!-- #  -->
<!-- # - **Objective**: Detect a difference from 40% to 60%. -->
<!-- # - **Parameters**: -->
<!-- #   - \( p_1 = 0.40 \), \( p_2 = 0.60 \) -->
<!-- #   - \( \alpha = 0.05 \) -->
<!-- #   - Power = 80% -->
<!-- # - **Calculation**: Use the sample size formula for proportions. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Key Takeaways -->
<!-- #  -->
<!-- # - **Critical Role of Sample Size**: Essential for valid and credible results. -->
<!-- # - **Interplay of Factors**: Effect size, variability, power, significance level, and dropouts. -->
<!-- # - **Estimates and Assumptions**: Recognize uncertainties in parameters. -->
<!-- # - **Special Designs**: Crossover and adaptive trials require specific considerations. -->
<!-- # - **Collaboration and Planning**: Engage with experts and use appropriate tools. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Conclusion -->
<!-- #  -->
<!-- # Sample size estimation balances scientific objectives with practical constraints. By carefully considering various factors and employing rigorous methods, researchers can design studies that are both efficient and effective. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Questions and Discussion -->
<!-- #  -->
<!-- # We welcome any questions or comments you may have. Thank you for your attention. -->
<!-- #  -->
<!-- #  -->
<!-- #  -->
<!-- # # Appendix A: R Code Examples -->
<!-- #  -->
<!-- # ## Sample Size Calculation for Comparing Two Means -->
<!-- #  -->
<!-- # ```{r} -->
<!-- # # Install and load the pwr package -->
<!-- # if (!requireNamespace("pwr", quietly = TRUE)) { -->
<!-- #   install.packages("pwr") -->
<!-- # } -->
<!-- # library(pwr) -->
<!-- #  -->
<!-- # # Parameters -->
<!-- # effect_size <- 5 / 15  # Effect size (Cohen's d) -->
<!-- # power <- 0.8           # Desired power (80%) -->
<!-- # sig_level <- 0.05      # Significance level (alpha) -->
<!-- #  -->
<!-- # # Sample Size Calculation -->
<!-- # result <- pwr.t.test(d = effect_size, power = power, sig.level = sig_level, -->
<!-- #                      type = "two.sample", alternative = "two.sided") -->
<!-- #  -->
<!-- # print(result) -->
